http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006503040-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
filingDate 2003-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2006503040-A
titleOfInvention Cycloalkylamine derivatives consisting of heterocyclic fused benzodioxanes as antidepressants
abstract The compounds of formula I include depression (including but not limited to major depression, childhood depression, and mood modulation), anxiety, panic disorder, post-traumatic stress disorder, premenstrual discomfort disorder (also called premenstrual syndrome) ), Attention deficit disorder (with and without hyperactivity), obsessive compulsive disorder (including but not limited to hair loss), obsessive compulsive spectrum disorder (including but not limited to autism), social anxiety Useful for the treatment of disorders, generalized anxiety disorders, obesity, eating disorders, vasomotor facial flushing, cocaine and alcoholism, sexual dysfunction and related disorders. [Chemical 1]
priorityDate 2002-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002510682-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001515485-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5607961-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467079051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466181060
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466386510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466386498
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468128617
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467727250

Total number of triples: 38.